Airlines from China, US on stable path to raise flights after agreement

Airlines from China and the US are on a stable path to increase flights between the two countries, recording the biggest jump since the outbreak of the pandemic, amid recent efforts by the Chinese and US governments to increase flights.

On Monday, US-based Delta Air Lines said that it would increase the frequency of nonstop services between Shanghai-Pudong and Detroit to daily flights, beginning on May 23.
Delta is currently operating daily flights from Shanghai-Pudong to Seattle and three-times-weekly services to Detroit.

After the change, Delta will operate two daily flights from Shanghai to its US gateways.

Delta is not alone.

United Airlines said earlier this month that it would add four weekly flights between Los Angeles and Shanghai starting on August 29. Further, in late October, the Shanghai-Los Angeles route will be increased to daily service. This service complements United's daily service between San Francisco-Shanghai and San Francisco-Beijing.

In addition, six Chinese airlines including Air China, China Southern Airlines and China Eastern Airlines, which serve routes between the two countries, all announced new flight schedules to the US.

Air China will add one flight per week between Beijing and Los Angeles and two flights per week between Beijing and New York from March 31, and China Eastern will add two weekly flights from Shanghai to Los Angeles and one weekly flight from Shanghai to San Francisco starting from March 31.

China Southern will add one new weekly flight from Guangzhou to Los Angeles on March 31, and two new weekly flights from Guangzhou to San Francisco on April 2.
The new flights between China and the US operated by Chinese airlines are still mostly concentrated in Los Angeles and San Francisco in the western US.

The announcements came after the agreement made by the Chinese and US governments recently. Starting on March 31, airlines from China and the US can operate a total of 100 scheduled round trips per week, according to the Civil Aviation Administration of China on February 29.

China and the US have seen increasing flights in recent years, and this round of increases is the biggest jump since the outbreak of the pandemic. There were three rounds of increases in 2023, and the latest was up from 48 flights to 70 flights, starting from November.

However, the total number of flights linking China and the US is still lagging behind the level of 2019. Even after this increase in flights, the level of recovery still lagged behind those among other countries.

In 2019, daily passenger flights between China and the US averaged 165, with a daily peak of 181, data from information provider VariFlight showed.

Data from Fly Master showed that China's outbound passenger flights during the Spring Festival period recovered to 69.3 percent of the level in 2019.

The destinations were concentrated in East Asia and Southeast Asia, with South Korea, Thailand and Japan ranking in the top three. In terms of the recovery rate, Singapore, the United Arab Emirates and the UK exceeded 100 percent.

Chinese biotech firms say US bill to harm fair competition

The US Senate's homeland security committee approved a bill on Wednesday (US time) to prohibit contracts with Chinese biotech providers including BGI Group, MGI and Complete Genomics, in the latest move by Washington to expand its suppression of Chinese companies in this new field of medicine under the guise of national security.

While the bill has a long way to go before becoming law, it reportedly aims to ban US federal agencies and the US government from contracting with these Chinese firms.

"BGI, WuXi AppTec and other highly subsidized companies seek to undercut their way into dominating the US biotech market while aggressively collecting the genetic and other sensitive medical data of tens of millions of Americans and transferring it back to China for malign or unknown purposes," US Senator Bill Hagerty alleged, according to a post on Hagerty's official website on Wednesday.

In a response, BGI Group said it fully supports the bill's premise of protecting Americans' personal data, but driving BGI out of the US, which is what this bill is intended to achieve, is unlikely to accomplish its goal since BGI does not have access to that data.

"The bill will limit competition and strengthen the market monopoly in the important field of human genome sequencing by using the legislative process to pick winners and losers," BGI told the Global Times on Thursday.

In a statement released on Thursday, WuXi AppTec said that it strongly disagrees with the US Senate's "preemptive and unfair" move of designating it as a "biotechnology company of concern" in its draft bill.

"WuXi AppTec has not posed, does not pose, and will not pose a security risk to the US or any other country," the company said.

Wuxi Biologics (Cayman) Inc clarified on Thursday that it is not a subsidiary of Wuxi AppTec Co. The company said it does not have a human genomics business, nor does it collect human genomic data in any of its businesses, while also stressing that it does not pose any national security risk to the US or any other country.

Chinese observers blasted US politicians, who they said were portraying China as an "imagined enemy" and expanding a crackdown on Chinese bio-tech and new-energy vehicle (NEV) companies.They said that American politicians are purposely setting obstacles to impede normal China-US economic and trade ties.

"This is another typical case in which US politicians purposely make China an 'imagined enemy' to step up suppression of Chinese companies for their own political gains, as the US presidential election draws near," Li Yong, a senior research fellow at the China Association of International Trade, told the Global Times on Thursday.

What US politicians are concerned about is that they cannot live in a world led by Chinese companies, and they have come up with every excuse to hinder China's development in a wide range of sectors including telecommunications, NEVs and now bio-technology, Li said.

"While China and the US are expanding their dialogues, what the US is doing has posed impediments to normal China-US trade," he said. He urged the US to correct its wrongdoing.

Recent media reports said that US President Joe Biden will sign an executive order to prevent foreign entities from accessing troves of Americans' personal data.

"The US overstretches the concept of national security, falsely accuses China of purchasing Americans' personal and sensitive data for malicious activities, and prevents the transfer of data to so-called 'countries of concern' including China," Chinese Foreign Ministry spokesperson Mao Ning said at a recent press conference on February 29, 2024.

"The Chinese government takes data privacy and security very seriously. We have never asked and will never ask any company or individual to collect or provide data, information or intelligence located abroad against local laws for the Chinese government," Mao noted.

China issues guidelines for flexible job market in bid to boost employment

In a bid to enhance services for flexible workers, China's Ministry of Human Resources and Social Security (MHRSS) issued a comprehensive set of guidelines aimed at standardizing flexible job markets on Monday, aiming to provide workers with transparent and regulated services. The notice is in line with its commitment to integrate this sector into the broader employment public service system. 

In the notice, the MHRSS outlined several key areas related to flexible job markets that require attention and improvement.

China has a vast population of flexibly employed individuals, and the rapid development of the internet industry has sparked changes in the job market, making it easier for young people to find such jobs, but the market remains largely unregulated, Tian Yun, a veteran economist based in Beijing, told the Global Times on Monday.

The notice emphasized the need to clearly define the service orientation of flexible job markets. The markets, which often operate outside the public service sector, will now be brought under the umbrella of the public employment service system, providing accessible, flexible and inclusive labor services.  

The ministry also said it aims to improve services in the markets, stressing the importance of providing comprehensive services such as job matching, career guidance, and skills training, which is particularly significant in light of China's rapidly evolving job market, where new sectors and opportunities are constantly emerging.

The notice also highlighted the opening and operation of flexible job markets, and called for building service stations and recruiting sites that meet local workers' conditions and demands. It also clarified the roles and responsibilities of various stakeholders in managing and overseeing the markets.

Data analysis is an important part of the notice, as job markets will be asked to publish key indicators, such as the ratio of job seekers to available positions. The information is critical for job seekers and employers in making decisions.

Standardizing service requirements is another part of the notice. The MHRSS has asked local departments to standardize naming rules for local job markets, to unify business processes and service standards, and implement clear regulations to ensure transparency in services. The ministry will soon publish a unified national logo for the markets across the country.  

The notice also underscored the importance of capacity building within the sector, which includes measures such as enhancing staff training and expanding the workforce through multiple channels to cater to the growing demands of this dynamic market.

Many flexible workers lack adequate protection for their labor rights. The notice from the MHRSS provides directional guidance for developing the flexible job markets, but concrete implementation by local authorities is needed to ensure compliance. Regulating flexible employment requires a concerted effort from the relevant authorities, as well as support and cooperation from society, Tian said.

World cannot return to a state of isolation; China opposes all form of unilateralism: FM

Chinese Foreign Ministry Spokesperson Wang Wenbin on Wednesday said the world cannot return to a state of isolation and that China opposes all forms of unilateralism and protectionism in response to International Monetary Fund (IMF) warning that fragmentation of the global economy and increasing national security restrictions could lead to a 7 percent loss in global GDP.

Whether it is trade wars or technological battles, the underlying objective is to politicize, instrumentalize, and weaponize economic and trade issues. The aim is to secure a monopoly on their own developmental advantages, impede the growth of emerging markets and developing nations, and deny the 7 billion people worldwide their right to pursue a happy life, Wang said.

Wang said that China is willing to work with all parties to promote universally beneficial and inclusive economic globalization. China firmly opposes deglobalization and overstretching the national security concept, and opposes all forms of unilateralism and protectionism.

The remarks come as the IMF warned that global economic fragmentation could lead to a 7 percent loss in global GDP.

IMF Managing Director Kristalina Georgieva told CNN in an interview aired on Tuesday local time that restrictions related to "national security" are increasing, and geopolitical factors are causing economic divisions worldwide. 

Allowed to continue, this could ultimately reduce Global GDP by 7 percent - roughly equal to the annual output of France and Germany, she said.

"So we are all better off to find ways to reduce frictions, to concentrate on security concerns that are real and meaningful, and not go willy-nilly in fragmenting the world economy. We would end up with a smaller pie," she said.

Wang said that the world cannot return to a state of isolation and cannot be arbitrarily divided. Any practice of seeking selfish gains at the expense of neighbors, any mindset of confrontation between camps, and any arrogance of self-centeredness will not lead to good results.

China will promote equal rights, equal opportunities, and equal rules for all countries, safeguarding the development rights of all countries, and working toward common development and prosperity.

The IMF's report in October 2023 predicted a slowdown in global economic growth from 3.0 percent in 2023 to 2.9 percent in 2024.

Veteran skater Fan Kexin kisses ice surface at ISU World Cup in Beijing

China's veteran short track speed skater Fan Kexin kissed the ice surface at the Capital Indoor Stadium again on December 9 at the ISU Short Track World Cup in Beijing, as she returned to competition after a nearly two-year hiatus after the Beijing 2022 Winter Olympics.

Fan, who is among China's squad that won a gold medal in the 2,000-meter mixed relay at the home Olympics, finished her events on Saturday with two silver medals.

Fan clocked the women's 500 meters with 43.117 seconds, followed by her younger teammate Wang Ye with 43.176 seconds. At the awarding ceremony for the race, Fans kissed the ice surface again.

"I just love this ice so much," Fan, a three-time Olympian, told reporters after Saturday's races at the ISU short track World Cup event in Beijing. "As long as I have chances to compete, I will do my best."

Fan noted that now she is enjoying skating, thanks to the overwhelming support from Chinese fans.

"Their support means a lot to us. Now we are receiving massive attention from the fans compared to the past, which also boosted our confidence and performances," the 30-year-old said.

Fan's kiss on the ice surface at the Olympics was remembered as one of the emotional moments at the quadrennial event by Chinese short track fans.

Speculation was rampant that the Beijing 2022 Winter Olympics would be Fan's swansong, as she had not participated in any competition since.

Her return has been considered a boost for the Chinese women's short track team, which is currently in a rebuilding phase as it aims to return to the sport's top-tier.

Along with her younger teammates, Fan is also among the team that won a silver medal in the 2,000-meter mixed relay at the World Cup event. Her younger teammate Wang, who is just 18, has welcomed her return, crediting Fan who "strengthened" the whole team's confidence with competing.

Speaking about the winning inheritance of the short track team, which is the most successful Chinese winter sports team, Fan said it is not just "talk the talk."

"The inheritance is in their hearts to take on the task and responsibility to grow, rather than just talking out loud about inheritance," Fan said.

"It feels great to compete with my young teammates side by side. I hope these young athletes could participate in the World Cup, World Championships, the Olympics step by step and achieve better results."

Short track competitions are currently the most popular winter sports races in China, as the stadium hosting Chinese athletes often has near-capacity attendance drawn by the chance to witness the star-studded national squad.

Saturday's race saw Team China bag four silver and one bronze medals. The competitions will continue on Sunday, including a highly-anticipated men's 5,000-meter relay final.

A Xinjiang hospital's Key State Lab signs deal with Kazakhstan center to enhance cooperation on treatment of high incidence diseases and organ transplantation

A Xinjiang hospital's Key State Lab has signed a deal with the Kazakhstan National Medical Science Center to enhance cooperation on prevention and treatment of high incidence diseases in Central Asia. Additionally, the Xinjiang Medical University Hospital also signed a parallel agreement for surgery and organ transplantation. The signing marks an increased role for China in helping improving the health conditions of Central Asian countries with the support of the China Organ Transplant Development Foundation.

The deal was signed by the Kazakhstan center with The First Affiliated Hospital of Xinjiang Medical University and the hospital's Key State Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, at the 7th China-International Organ Donation Conference and the Belt & Road Symposium on Organ Donation and Transplantation International Cooperation Development in Nanning, South China's Guangxi Zhuang Autonomous Region on Saturday.

After the signing of the deal, Kazakhstan will send medical personnel to study at the Xinjiang Medical University hospital and Key State Laboratory specifically for research and treatment against high incidence diseases in Central Asia, Wen Hao, head of the Key State Lab of Xinjiang Medical University, told the Global Times on Saturday. The laboratory and the hospital are well-equipped and host a wide range of departments, "thus we can answer almost any technical request from the Kazaks. who are also thrilled about it," Wen said.

Wen said that the Key State Laboratory was opened in 2017. It is actively working with five Central Asian neighboring countries on training, as well as studying and treating major diseases in these areas, such as cervical cancer and esophageal cancer. Additionally, zoonotic cardiovascular diseases, diabetes, and cerebrovascular diseases are also prevalent and pose the greatest threat to the people's health in Central Asia.

Ever since the Key State Laboratory was established, it has been working to strengthen cooperation with Central Asian countries. Wen noted that China is ahead of neighboring countries in terms of scale, quality, and national standards of medical care, which is one of the reasons these countries are interested in working with China. .

In July of this year, the Xinjiang hospital assisted the Kazakhstan National Medical Science Center in successfully treating a patient with alveolar Echinoccosis by using Exvivo Liver Resection & Autotransplantation (ELRA) for the first time.

Wen stated that in active response to the Belt and Road Initiative, his lab and hospital had dispatched a team of medical experts to Central Asian countries, such as Kazakhstan, Kyrgyzstan and Uzbekistan. Through medical technology exchanges, hosting bilateral academic forums, and establishing technology promotion and training bases, the hospital aims to continuously deepen and broaden cooperation with these Central Asian countries, seeking to enable people in these countries to access and benefit from high-quality medical resources.

In May of this year, China and five Central Asian countries jointly signed the Xi'an Declaration of the China-Central Asia Summit, which was held in Chinese city of Xi'an. In the declaration, all sides agreed to further deepen health and medical cooperation, promote the construction of traditional Chinese medicine centers, and carry out herbal planting and processing cooperation to create a healthy "Silk Road."

After China has improved its own work on organ donation and transplantation, sharing expertise with countries participating in the Belt and Road Initiative has also become very important. Aims include pushing forward their development in this regard, and assisting them with the development of local medical systems and technology, Huang Jiefu, chairman of China Human Organ Donation and Transplantation Committee and Chair of COTDF Advisory Board told the Global Times on Saturday.

Wen said that in recent years, countries such as India, South Korea, Japan, and some Western countries, have been trying to exert influence over Central Asia. He mentioned that Abay Baigenzhin, Chairman of the Management Board of Kazakhstan National Medical Science Center, told him that cooperation with Western countries usually involves big promises but little action. However, after enhancing cooperation with China, Kazakhstan appreciated that China not only kept its promises, but also had the ability to implement projects.

Wen also noted that now China is offering preferential policies for medical students from Central Asian countries, which has facilitated medical exchanges between China and the region. "Such cooperation is helpful for people-to-people exchanges between China and those countries; and there is no basis for attacking or smearing efforts to help people cure diseases."

"In the next two years leading up to 2025, we should expect to see more practical cases of collaboration, inspiring stories, and data to support our cooperation in organ transplantation and donation with Central Asian countries. These developments will further bolster our contributions to the prevention, diagnosis, and treatment of prevalent diseases in Central Asia, as well as the promotion of public health across the region regions," said Wen.

China's first mass-produced WZ-16 engines delivered

China's first mass-produced WZ-16 turboshaft engines were recently delivered, marking yet another achievement in the country's aero engine sector, which used to trail behind the global top standard, experts said on Sunday.

A delivery conference was held in Harbin, Northeast China's Heilongjiang Province, on Friday, according to a press release from the state-owned Aero Engine Corporation of China (AECC) published on its WeChat account on Saturday.

The press release did not give details on the delivery, including the engine's customers or the number of engines delivered. At least three engines can be seen in a photo attached to the press release.

This marks a key step in the industrial development of the AECC's aero engine products for civilian purposes, and fully displays China's capabilities in research and development as well as marketing in this high technology sector, the AECC said.

The WZ-16 is a latest type of turboshaft engine that was strictly developed and certified in accordance with airworthiness regulations, the AECC said, noting that with a takeoff power of more than 1,240 kilowatts, a weight of less than 223.5 kilograms, a fuel consumption rate of less than 294 grams per kilowatt-hour and a service ceiling of 6,000 meters, the engine's overall performance has reached an internationally advanced level with high reliability and a long overhaul interval.

Having obtained type certification in October 2019 and production certification in March 2021, the WZ-16 can be equipped by seven ton-class twin-engine helicopters such as the AC352 (also known as the Z-15) and see wide applications in fields such as search and rescue, offshore drilling operations, personnel transport, medical aid and commercial flights, the company said.

The Z-15 medium-sized, multipurpose helicopter was awarded a qualification certificate by the Civil Aviation Administration of China in July 2022, marking the successful development of this type of chopper, which is now eligible to enter China's civilian market, the Global Times learned from the state-owned Aviation Industry Corporation of China, the helicopter's maker.

China's aero engine technology used to lag behind the world's top standard for decades, and now it is seeing significant achievements in many fields, a Chinese aviation expert who requested anonymity told the Global Times on Sunday.

In recent years, China's top military aircraft like the J-20 fighter jet and the Y-20 transport aircraft have converted to using domestically developed turbofan engines, and now civilian helicopters are getting advanced turboshaft engines, the expert said, noting that Chinese aero engine developers' efforts are beginning to bear fruits, and that more advanced engines are likely under development.

China sees 40,200 organ donations from 2015 to 2022

China saw more than 40,200 deceased organ donations from 2015 to the end of 2022, with 120,100 major organs donated. Additionally, more than 6.55 million people have voluntarily registered for organ donations, according to the China Organ Transplant Development Foundation (COTDF).

The COTDF revealed the figure at the 7th China-International Organ Donation Conference and the Belt & Road Symposium on Organ Donation and Transplantation International Cooperation Development, which kicked off in Nanning, South China's Guangxi Zhuang Autonomous Region, on Saturday.

Currently, China ranks second in the world and first in Asia in terms of the number of organ donations, benefiting numerous patients in need. The COTDF said that 5,628 deceased organ donations were made in 2022, an increase of 6.75 percent compared to 2021.

More than 20,000 organ donations are made in Chinese mainland each year, ranking second in the world in terms of data. However, organ donors per million people (PMP) is less than 4 percent, which is far from satisfactory compared to the 47 percent in developed countries, Huang Jiefu, chairman of China Human Organ Donation and Transplantation Committee and chair of the COTDF Advisory Board, told the Global Times on Saturday.

He pointed out that there are not enough hospitals in China to satisfy patients' demand for organ transplants. "China currently has only slightly more than 70 hospitals that perform heart and lung transplants. Thus, there is still a shortage of doctors and hospitals to meet the needs of the people," said Huang.

In October, China's State Council held an executive meeting that adopted a draft revision to the regulations on donation and transplantation of human organs.

The government aims to establish a system for tracing and supervising the whole procedure of donating and transplanting human organs. It will enhance ethical reviews on how human organs are obtained and crack down on crimes involving human organs, according to the meeting.

Talking about the revision, Huang used the phrase "scraping poison off the bone" to describe the determination in China's organ donation reform.

He said that under the leadership of the central government, this reform has achieved significant victories and has been widely recognized by the international community. The revision of the regulation demonstrates the Party and the country's emphasis on organ donation, providing strong legal protection for the high-quality development of the organ donation cause, said Huang.

Huang said that the word "donation" carries special meaning. With the coming of the regulation, organ donations will be more transparent, and it also calls for more people to get involved in organ donations and transplants. In the future, it is hoped that China's organ transplantation technology will spread to more countries in the Belt and Road Initiative via the Organ Donation and Transplant under the Framework of the Belt and Road Initiative, said Huang.

Talking about China's recent achievements in organ transplantation, John Fung, president-elect of the Transplantation Society, told the Global Times that in terms of survival, China meets international standards.

"The primary accomplishment of China's transplant efforts is that a country that had very limited transplants 30 years ago is now able to compete with any other transplant program in the world in terms of quality," said Fung.

However, Fung also mentioned that the primary challenge in China is that "it has a very large population and still not enough access to transplants. There are many barriers to transplants for the common people in terms of costs as well as a shortage of organs."

Yet he said that China is getting there as the trajectory of donations in the country is increasing fast, thus he is confident that five years from now China will move to a much higher rate of donation.

The Belt & Road Symposium on Organ Donation and Transplantation International Cooperation Development held a launch ceremony, during which those in attendance agreed to establish a series of action plans in the areas of leadership, management, quality control and technological innovation in organ donations and transplantations based on the principles outlined by WHO Guiding Principles on Human Cell, Tissue and Organ Transplantation.

Through continuous strengthening of interaction, deepening of mutual trust, and fostering of friendship, the goal of self-sufficiency in organ donation will be achieved.

Fung also mentioned that there is an organized conspiracy on the international stage that tries to play down the accomplishments of China's organ donation experience, by feeding misinformation about transplants in China to further damage the country's reputation.

For example, a new wave of accusations of "organ harvesting" in China has emerged. Following some Western media reports from the China Tribunal, which accused the Chinese government of "harvesting organs from Falun Gong practitioners" and Uygurs "detained in camps" since June 2019, VICE magazine's France version also released a new report on the same topic on June 19, offering more so-called "evidence."

By digging into those stories, the Global Times has found out that such claims are lies interwoven by members of the Falun Gong cult, separatists from Xinjiang and overseas anti-China forces with the purpose to further paint China as a devil mistreating minorities in Xinjiang, to smear the country's organ transplantation and donation system and its anti-terrorism work in Xinjiang, and to instigate the international community to further pressure China.

In response to this recent slander, Huang said that China's reform on organ transplantation is to keep friends close and keep enemies closer. "You can never wake up someone who is pretending to be asleep… we are not afraid of those slanders, as long as what we are doing is justified and is on the right course."

Fung suggested that more publications about "China's organ transplantation be disseminated globally for people to understand that China complies with international standards and that their outcomes for transplantations are as good as anybody else's. As transplantation society president I will do my best to make it more open for the world to understand and appreciate w